100
Participants
Start Date
December 31, 2013
Primary Completion Date
September 30, 2014
Study Completion Date
December 31, 2014
Low dose of H7 VLP vaccine + Alhydrogel
Low dose of H7 VLP vaccine mixed with Alhydrogel, 2 doses given 21 days apart
Med dose of H7 VLP vaccine + Alhydrogel
Med dose of H7 VLP vaccine mixed with Alhydrogel, 2 doses given 21 days apart
High dose of H7 VLP vaccine + Alhydrogel
High dose of H7 VLP vaccine mixed with Alhydrogel, 2 doses given 21 days apart
High dose of H7 VLP vaccine
High dose of H7 VLP vaccine, 2 doses given 21 days apart
Placebo
Placebo, 2 doses given 21 days apart
Canadian Science Centre for Human and Animal Health, Winnipeg
Lead Sponsor
Collaborators (1)
Health Sciences Centre, Winnipeg, Manitoba
OTHER
Public Health Agency of Canada (PHAC)
OTHER_GOV
Syneos Health
OTHER
Medicago
INDUSTRY